key: cord-0755801-8xw6ouox authors: Mukunoki, Hiroshi title: Comment on “How COVID‐19 Medical Supply Shortages Led to Extraordinary Trade and Industrial Policy” date: 2021-08-30 journal: Asian Economic Policy Review DOI: 10.1111/aepr.12367 sha: 8c059ab2758b270dae2108452058ee35e5786cb3 doc_id: 755801 cord_uid: 8xw6ouox nan political relations are related to China's export pattern of critical medical goods. It is interesting to discuss what political factors affect the noncommercial trade of PPE products. For instance, the US-China tariff wars and other aspects of their "decoupling" might jeopardize the donation exports of PPE from China to the USA. Third, it is worth considering the role of digital technology in mitigating supply shortages of PPE. By transmitting design data of PPE from exporting countries, importing countries will be able to manufacture PPE using three-dimensional (3D) printing. Such 3D-printable products include face shields, masks, goggles, and other medical equipment. For instance, China increased its exports of "Machinery for working rubber or plastics or for the manufacture of products from these materials" (HS8477), which should include 3D printers, in the latter half of 2020. This observation indicates that Covid-19 has increased the demand for 3D printing. Although many countries have waived tariffs on imported PPE after the pandemic, they should widen the scope of tariff-free products to manufacture PPE. For instance, the USA's most-favored-nation tariff on 3D printers is 3.5%, and the Consumer Technology Association has requested to the United States Trade Representative to waive tariffs on digital-related products, including 3D printers (see Shepardson, 2020) . Besides that, facilitating cross-border data flows will help the spread of digital technologies that mitigate Covid-19 damage, implying that the rise of digital protectionism makes countries more vulnerable to shocks. Fourth, regarding the domestic stockpile of PPE, the potential supply capacity is underestimated if we only focus on manufacturers of medical goods. For instance, Toyota used its facilities in the USA to make face shields and masks, and supplied them to nearby hospitals. Other automotive companies, such as General Motors, Ford, and Tesla, have also begun to produce face shields and respirators in their factories. Flexible manufacturing might be a key to establish a "just-in-case" system for PPE. Finally, Bown should discuss its correspondence to the existing empirical analyses on trade effects of Covid-19, such as Friedt and Zhang (2020), Meier and Pinto (2020) , and Hayakawa and Mukunoki (2021) . For instance, Hayakawa and Mukunoki (2021) find positive effects of Covid-19 damages on imports of medical products, whereas persistent negative effects were observed for nonessential products. How COVID-19 medical supply shortages led to extraordinary trade and industrial policy The triple effect of Covid-19 on Chinese exports: First evidence of the export supply, import demand and GVC contagion effects Mask wars: China's exports of medical goods in times of COVID-19 Impacts of COVID-19 on international trade: Evidence from the first shock COVID-19 supply chain disruptions U.S. coronavirus tariff exemptions sought for robots, drones, elevators. Reuters